Kermode Biotechnologies is dedicated to developing prophylactic, therapeutic, and diagnostic products to treat a wide range of animal viruses. We are currently focused on livestock viruses including Swine Influenza and African Swine Fever Virus.
By treating animals that have close contact with humans, we aim to considerably reduce the occurrence of viral crossover into humans, known as zoonosis, and prevent future pandemics.

Kermode applies an artificial intelligence platform to analyze virion structural, genetic, and viral replication properties to create spatial blueprints for vaccine and therapeutic development strategies. For example, our lead products for ASFV treatment in swine have been derived by exploiting previously unknown complexities in its viral replication cycle.